The Basis of Genetics. The Cell Cycle Cell Signaling.

Slides:



Advertisements
Similar presentations
Research Leaders: Meeting the challenge Mark Walport 19 November 2008.
Advertisements

1 Pharmaceutical Challenges for the Semantic Web.
1 Biomedical Sciences Public and Environmental Health Regenerative Medicine Translational Research.
THE GENETIC OF CANCER Increased mitosisTumor formation Tumor suppression gene Hyperactive growth TranslocationPoint mutationAmplification Normal growth.
What Do Toxicologists Do?
David M. Margolis, MD Professor of Medicine Towards an HIV cure: medical, social and ethical challenges in research and testing.
KRAS testing in colorectal cancer: an overview. 2 What is KRAS? KRAS is a gene that encodes one of the proteins in the epidermal growth factor receptor.
Anticancer Therapy: Kinase Inhibitors Charles Harrell.
White blood cells & the immune system What does it mean to be immune to something? Leucocyte (WBC) Phagocytes (engulf & destroy) = Inflammation Lymphocytes.
KEY CONCEPT Genetics provides a basis for new medical treatments.
CELLULAR BIOLOGY IN BREAST CANCER JESSE ELLMAN MD SEPT 2010 CLINICAL ASSISTANT PROFESSOR DEPT OB GYN AND WOMENS HEALTH WE MAY BE ENTERING A NEW PHASE.
Cancer: when our own cells become the enemy
Advanced Cancer Topics Journal Review 4/16/2009 AD.
The HCV vaccine: cooperation in the shadow of the pyramids Antonella Folgori.
Annual prostate cancer symposium February 23, 2013 The Kimmel Cancer Center, Philadelphia, PA 2nd “ Novel Therapeutic Strategies for Prostate Cancer ”
Clinical Division of Oncology Department of Medicine I Medical University of Vienna, Austria Cancer Biology.
The Future of Cancer Care The Future of Cancer Care Stephen C. Schimpff Executive Vice President, UMMC Interim Director, University of Maryland Greenebaum.
Antibody and prodrug therapy of cancer
Computational biology of cancer cell pathways Modelling of cancer cell function and response to therapy.
1 Genomics and the Human Condition Francis S. Collins, M.D., Ph.D. Dedication of Ken Olsen Science Center Gordon College September 27, 2008.
Aging Baby Boomers Predicted to Drive up Incidence of Cancer.
Gene Therapy Clinical Trials. Cancer Gene Therapy Three Basic Approaches. Genetically alter a person's immune cells that are already naturally targeted.
KEY CONCEPT Genetics provides a basis for new medical _____________.
Oncopathophysiology Tornóci László Semmelweis University Institute of Pathophysiology.
Genes and Development Chapter 16. Development All the changes that occur during an organism’s lifetime Cell specialization: Cell determination: specific.
D4FF55A0-6B6F BF422A9BA9 Present by: Xiao Chen On December 7, 2015.
Cancers of the Digestive System November 19, 2007 NCDD Meeting Chair: John M. Carethers, MD Vice Chair: Robert Sandler, MD, MPH.
BIOSTATISTICS Lecture 2. The role of Biostatisticians Biostatisticians play essential roles in designing studies, analyzing data and creating methods.
Melanoma is a cancerous cell which is caused from the sun. It can quickly spread from the surface of the skin to other parts of the body.
Progress in Cancer Therapy Following Developments in Biopharma
Molecular Biomarkers & Targets an overview Michael Messenger NIHR Diagnostic Evidence Co-Operative & Leeds Cancer Research UK Centre.
RISE Honors Seminar 2014 Ronald Doll RISE Dept. S-332 X 3168 Training – Synthetic Organic Chemist (Ph.D. Duke Univ.) - National Institute.
XXV^ Riunione Nazionale MITO Innovation in gynecologic cancer: optimal therapy, quality of life, precision medicine. Naples, June Targeting.
© 2016 Global Market Insights, Inc. USA. All Rights Reserved Fuel Cell Market size worth $25.5bn by 2024 Precision Medicine Market worth.
New research areas in personalised medicines
Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.
Treating 35 million people with ART – where are we?
Yale SPORE in Skin Cancer
MONOCLONAL ANTIBODIES AGAINST NERVE GROWTH FACTOR IN PAIN MANAGENT
National and International Efforts worth knowing about
Genes and Development CVHS Chapter 16.
Anti-therapeutic antibodies Creative Biolabs is a pioneer and undisputed global leader in the rapidly emerging market for therapeutic antibodies. We offer.
Therapeutic antibodies Creative Biolabs is a pioneer and undisputed global leader in the rapidly emerging market for therapeutic antibodies. We offer a.
Anti-therapeutic antibodies Creative Biolabs is a pioneer and undisputed global leader in the rapidly emerging market for therapeutic antibodies. We offer.
From Bench to Clinical Applications: Money Talks
Knowledge l Action l Impact
Molecular targeted therapies in hepatocellular carcinoma: From pre-clinical models to clinical trials  Pippa Newell, Augusto Villanueva, Josep M. Llovet 
QUIZ QUESTIONS 1) WHAT ARE THE TWO TYPES OF CERVICAL CANCER?
Trinity College Dublin 12 April 2018 Hugh McMahon
KEY CONCEPT Genetics provides a basis for new medical treatments.
c-Kit as a Novel Potential Therapeutic Target in Colorectal Cancer
Nat. Rev. Clin. Oncol. doi: /nrclinonc
Are We Closer to Personalized Medicine in MS?
Nat. Rev. Urol. doi: /nrurol
KEY CONCEPT Genetics provides a basis for new medical treatments.
Treatment Overview: The Multidisciplinary Team
Toru Furukawa  Clinical Gastroenterology and Hepatology 
KEY CONCEPT Genetics provides a basis for new medical treatments.
Figure 5 The mechanism underlying epithelial-to-mesenchymal
A. Craig Lockhart, Mace L. Rothenberg, Jordan D. Berlin 
Jacques Irani  European Urology Supplements 
Why Use Animals Unit 2-2.
Cancer is a Challenge Cancer is common in humans – a public health problem ~1 of every 3 women will develop cancer ~1 of every 2 men will develop cancer.
KEY CONCEPT Genetics provides a basis for new medical treatments.
KEY CONCEPT Genetics provides a basis for new medical treatments.
12th – 13th November GRANADA
A schematic representation of NOTCH signaling through DAB1–ABL–TRIO–RHO that stimulates colorectal cancer invasion and metastasis. A schematic representation.
KEY CONCEPT Genetics provides a basis for new medical treatments.
Simplified BRAF signaling network.
Patterns of clinical relapse and algorithm for the therapeutic strategy when AR to EGFR TKI occurs in patients with EGFR-mutant NSCLC. *After discussion.
Presentation transcript:

The Basis of Genetics

The Cell Cycle

Cell Signaling

Angiogenesis and Lymphangiogenesis

Metastasis

The Role of the Immune System in Cancer

Estimated Percentage of Cancer Deaths Attributable to Established Risk Factors

Cancers Due to Five Infections Correspond to 18% of Global Cancer Incidence

Colorectal Intraepithelial Neoplasia (IEN)

Imaging Modalities for Diagnosis and Imaging Response to Therapy

The Cancer Genome Atlas (TCGA)

Biomarkers Are the Foundation of Personalized Medicine

Drug Discovery and Development Timeline

Development of Imatinib (Gleevec)

Receptor Tyrosine Kinase Cell Signaling

Therapeutic Monoclonal Antibodies

Drug Resistance

Genetically Informed Clinical Trials

Cancer Occurs and Can Be Treated at Every Scale

The Public and Private Sectors Play Different Roles in Research

Lifetime Cancer Incidence

The Costs of Cancer

Clinical Trial Participation

Global Collaboration and Multidisciplinary Teams

Biomedical Research and Development Price Index (BRDPI)

National Research and Development Investment (Percent of GDP)

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com. Inc. All rights reserved.